Skip to main content

Inovio stock jumps on news of licensing deal with Advaccine for Covid-19 vaccine candidate

The deal includes a $3 million upfront payment and potential milestone payments of up to $108 million.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.